Key terms
About ICAD
iCAD, Inc. is a global medical technology company, which engages in the provision of cancer detection and therapy solutions. It operates through the Cancer Detection and Cancer Therapy segments. The Cancer Detection segment includes image analysis and workflow products. The Cancer Therapy segment relates to radiation therapy products. The company was founded in 1984 and is headquartered in Nashua, NH.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ICAD news
Apr 11
8:22am ET
iCAD showcases new ProFound Cloud at SBI symposium
Apr 03
8:03am ET
iCAD partners with RAD-AID to advance breast cancer detection
Apr 02
8:05am ET
iCAD announces commercial availability of ProFound Cloud
Mar 19
9:07am ET
iCAD releases enhanced ProFound Detection workstation
Mar 13
6:10am ET
Analysts Offer Insights on Healthcare Companies: iCAD (ICAD), Mustang Bio (MBIO) and Cerus (CERS)
Mar 12
8:56am ET
Craig-Hallum Gives a Buy Rating to iCAD (ICAD)
Feb 28
8:16am ET
iCAD highlights scientific presentations at ECR annual meeting
Feb 27
9:09am ET
iCAD appoints Hricak to board of directors
Feb 26
5:32pm ET
iCAD Inc Bolsters Board with Renowned Medical Expert
Jan 30
8:13am ET
iCAD appoints Michael Doyle to board of directors
Jan 26
4:57am ET
iCAD Inc Welcomes Michael John Doyle to Board
No recent press releases are available for ICAD
ICAD Financials
Key terms
Ad Feedback
ICAD Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ICAD Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range